Skip Navigation

Phase IIA Trial of Acolbifene 20 mg vs Low Dose Tamoxifen 5 mg in Pre-menopausal Women at High Risk for Development of Breast Cancer

Brief Summary

Type:
Breast Cancer

Study Type:
Prevention

Phase:
II

ClinicalTrials.gov Identifier:
NCT05941520

Study #:
STUDY00160550

Start Date:
Jul 01, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05941520

View Complete Trial Details & Eligibility at ClinicalTrials.gov